Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 | P30926 | 5/20 | 0.62 |
| ▸ | CHRNA3 | P32297 | 5/20 | 0.62 |
| ▸ | CHRNA1 | P02708 | 4/20 | 0.62 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.62 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.62 |
| ▸ | CHRNA2 | Q15822 | 3/20 | 0.62 |
| ▸ | CHRNG | P07510 | 2/20 | 0.62 |
| ▸ | CHRNB1 | P11230 | 2/20 | 0.62 |
| ▸ | CHRND | Q07001 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.56 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
| ▸ | HTR3B | O95264 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7749577 | 1.00 | CHRNB4 (0.62) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL5412359 | 0.83 | CHRNB4 (0.45) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL6972891 | 0.83 | CHRNB4 (0.60) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL159159 | 0.82 | CHRNB4 (0.64) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL31019621 | 0.82 | CHRNB4 (0.64) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL159158 | 0.82 | CHRNB4 (0.64) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL30866535 | 0.82 | CHRNB4 (0.64) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL1538368 | 0.81 | CHRNB4 (0.62) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL3059325 | 0.81 | CHRNB2 (0.62) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL1831992 | 0.81 | CHRNB4 (0.62) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0804195-A2 | DEPOLARIZING SKELETAL MUSCLE RELAXANTS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1997-11-05 | — | — | EP | claimed |
| WO-1996007410-A2 | DEPOLARIZING SKELETAL MUSCLE RELAXANTS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1996-03-14 | — | — | WO | claimed |
| US-20130131015-A1 | SYNTHESIS AND REGIOSELECTIVE SUBSTITUTION OF 6-HALO- AND 6-ALKOXY NICOTINE DERIVATIVES | UNIV NORTH CAROLINA STATE (US) | 2013-05-23 | — | — | US | disclosed |
| US-20130131015-A1 | SYNTHESIS AND REGIOSELECTIVE SUBSTITUTION OF 6-HALO- AND 6-ALKOXY NICOTINE DERIVATIVES | UNIV NORTH CAROLINA STATE (US) | 2013-05-23 | — | — | US | disclosed |
| US-20130131015-A1 | SYNTHESIS AND REGIOSELECTIVE SUBSTITUTION OF 6-HALO- AND 6-ALKOXY NICOTINE DERIVATIVES | UNIV NORTH CAROLINA STATE (US) | 2013-05-23 | — | — | US | disclosed |
| US-8389732-B2 | Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives | NORTH CAROLINA STATE UNIVERSITY (US) | 2013-03-05 | — | — | US | disclosed |
| US-8389732-B2 | Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives | NORTH CAROLINA STATE UNIVERSITY (US) | 2013-03-05 | — | — | US | disclosed |
| US-8389732-B2 | Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives | NORTH CAROLINA STATE UNIVERSITY (US) | 2013-03-05 | — | — | US | disclosed |
| US-20100331323-A1 | SYNTHESIS AND REGIOSELECTIVE SUBSTITUTION OF 6-HALO- AND 6-ALKOXY NICOTINE DERIVATIVES | COMINS DANIEL L | 2010-12-30 | — | — | US | disclosed |
| US-20100331323-A1 | SYNTHESIS AND REGIOSELECTIVE SUBSTITUTION OF 6-HALO- AND 6-ALKOXY NICOTINE DERIVATIVES | COMINS DANIEL L | 2010-12-30 | — | — | US | disclosed |
| US-20100331323-A1 | SYNTHESIS AND REGIOSELECTIVE SUBSTITUTION OF 6-HALO- AND 6-ALKOXY NICOTINE DERIVATIVES | COMINS DANIEL L | 2010-12-30 | — | — | US | disclosed |
| EP-1074256-A2 | Depolarizing skeletal muscle relaxants | R.J. REYNOLDS TOBACCO COMPANY (US) | 2001-02-07 | — | — | EP | disclosed |
| EP-0804195-A2 | DEPOLARIZING SKELETAL MUSCLE RELAXANTS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1997-11-05 | — | — | EP | disclosed |
| EP-0804195-A2 | DEPOLARIZING SKELETAL MUSCLE RELAXANTS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1997-11-05 | — | — | EP | disclosed |
| US-5559124-A | QUINUCLIDINE DERIVATIVE | TARGACEPT, INC., A CORPORATION OF DELAWARE | 1996-09-24 | — | — | US | disclosed |
| WO-1996007410-A3 | DEPOLARIZING SKELETAL MUSCLE RELAXANTS | REYNOLDS TOBACCO CO R (US) | 1996-05-30 | — | — | WO | disclosed |
| US-5510355-A | ADMINISTERING 2-(3-PYRIDYL)-QUINUCLILIDINE DERIVATIVE TO THE PATIENT UNDERGOING SURGICAL PROCEDURE REQUIRING ANESTHESIA AS A MUSCLE RELEXANT | TARGACEPT, INC., A CORPORATION OF DELAWARE | 1996-04-23 | — | — | US | disclosed |
| US-5510355-A | ADMINISTERING 2-(3-PYRIDYL)-QUINUCLILIDINE DERIVATIVE TO THE PATIENT UNDERGOING SURGICAL PROCEDURE REQUIRING ANESTHESIA AS A MUSCLE RELEXANT | TARGACEPT, INC., A CORPORATION OF DELAWARE | 1996-04-23 | — | — | US | disclosed |
| WO-1996007410-A2 | DEPOLARIZING SKELETAL MUSCLE RELAXANTS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1996-03-14 | — | — | WO | disclosed |
| WO-1996007410-A2 | DEPOLARIZING SKELETAL MUSCLE RELAXANTS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1996-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100331323-A1 | SYNTHESIS AND REGIOSELECTIVE SUBSTITUTION OF 6-HALO- AND 6-ALKOXY NICOTINE DERIVATIVES | CHRNA6, CHRNA7, CHRNA4 | CHRNB4 11/4885CHRNA3 5/4885CHRNA1 7/4885 |
| US-20130131015-A1 | SYNTHESIS AND REGIOSELECTIVE SUBSTITUTION OF 6-HALO- AND 6-ALKOXY NICOTINE DERIVATIVES | CHRNA6, CHRNA7, CHRNA4 | CHRNB4 11/4885CHRNA3 5/4885CHRNA1 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.